The rattlesnake (Crotalus adamanteus) is a venomous viper inhabiting the southeastern parts of the United States. It is not found in the Balkans and Europe habitats. Subjects of the species are grown and seen in museums, exhibitions and terrariums, and sometimes in private collections. This may generate potentially toxic exposures to the venom in accidental contact. Acute poisoning with rattlesnake poison in Bulgaria is exotic, rare and even casuistic. The venom of the rattlesnake exhibits neuropathic, proteolytic and hemolytic activities. Antivenom is not currently easily available in Bulgaria -it is not usually stored in hospitals because it is very rarely used and therefore rather expensive. We present a case of multiple envenomation (two different occasions) of one and the same person who kept rattlesnakes in a private terrarium. Local toxic syndrome was observed with burning and stinging pain at bite site combined with limited hemorrhage and necrosis. The hemolytic reaction and the local toxic results were successfully managed without resorting to any specifi c antidotal therapy.
INTRODUCTION
The rattlesnake (Crotalus adamanteus) is a venomous viper inhabiting the southeastern parts of the United States. This species has the reputation of being the most dangerous venomous snake in North America. 1 Europe is not the natural habitat of the snake. Until a few years ago rattlesnake bites were virtually unknown in Europe. But the biodiversity of European household fauna has changed: cats and dogs are increasingly replaced by stingrays, tarantulas, fi re fi sh and rattlesnakes. 2 Subjects of the rattlesnake species are grown and seen in museums, exhibitions and terrariums and sometimes in private collections. This may generate potentially possible toxic exposures to the venom in accidental contact. All in all rattlesnake poisoning is an exotic and rare casuistic event in Bulgaria.
We present two episodes of envenomation of one and the same person -a qualifi ed herpetologist who bred a rattlesnake (Crotalus adamanteus) in a private terrarium for 18 months. 
CASE STUDY

THE FIRST ENVENOMATION
DISCUSSION
Generally not aggressive, rattlesnakes are large and powerful. The mortality rate of snake bites is in the range of 10 -30%. 3 JH Brown gives the average dry venom yield from the snake to be 410 mg, LD 50 -1.3-2.4 mg/kg i.v., 1.7-3.0 mg/kg i.p. and 14.5-10 mg/kg s.c. for toxicity. 4 The estimated human lethal dose is 100-150 mg. 5 The venom contains a thrombin-like enzyme, called crotalase, that is capable of clotting fi brinogen, leading to the secondary activation of plasminogen from endothelial cells, a reduced platelet count and hemolysis of red blood cells. Even with this defi brination, however, clinically signifi cant bleeding is uncommon. Nevertheless, the venom does exhibit high hemorrhagic activity. It is believed that the poison contains a low-molecular-weight basic peptide that impedes neuromuscular transmission and can, in theory, lead to cardiac failure. In general, the venom can be described as highly necrotizing, mildly proteolytic and containing a large phosphodiesterase fraction. It stimulates the release of bradykinin that can result in severe pain, as well as profound, transient hypotension. 5 LM Klauber describes the symptoms as including instant pain 'like two hot hypodermic needles', spontaneous bleeding from the bite site, intense internal pain, bleeding from the mouth, hypotension, a weak pulse, swelling and discoloration of the affected limb and associated severe pain; the symptoms are strongly hemolytic and hemorrhagic. 6 The clinical presentation of the envenomation in the two consecutive episodes in one person in our study revealed typical signs and symptoms of the intoxication, but mild to moderate grade of severity. The case presented herein is consistent with the results of an epidemiological study in Germany and France, in which minor pathological changes were found (according to the Poisoning Severity Score in 78.7% and 8 of 23 cases of envenomation). 2 There were no other unusual findings -there were angioedema, bronchial spasm 7 or recurrent coagulopathy 8 as other authors have found. We were not able to follow up the patient due to his refusal. The patient received no antivenom therapy because antivenom was not available. The specifi c rattlesnake antivenom is not easily obtainable now in Bulgaria, it is not kept in storage due to its high price and the extreme rarity of usage. The hemolytic reaction and the local toxic results were successfully managed without any antidotal therapy mainly because of the small quantity of the injected poison in the episodes. There were no allergic reactions, either.
CONCLUSIONS
Rattlesnake bites are rare in Europe, but the incidence is rising. European doctors should be aware of the increase in these envenomations. Toxic envenomation may occur even in skilled herpetologists.
